This Biotech Stock Soared: Why One Fund Sold $3 Million
A biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
Using Index Level to adjust risk lets you scale exposure in line with market momentum, maintaining a balanced, rules-based approach.
27,116 articlesA biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
UBS analysts warn that aging housing stock could spark a repair-driven upcycle for major home-improvement retailers. ...
Cantor8 announces a major expansion into Africa's mobile money scene, linking M-PESA and EVC Plus to its Canton Netwo...
Birkenstock's 2026 earnings reveal how the brand is balancing direct-to-consumer growth with wholesale pressures. Thi...
Hyperliquid's AQAv2 upgrade pushes HYPE higher as Coinbase and Circle commit to the new stablecoin framework, alignin...
A wave of social security overpayment letters in 2024 has led to sizable clawbacks for vulnerable retirees. This repo...
Bank of America has reinstated its coverage on ServiceNow with a Buy rating, citing the platform's pivotal role in AI...
Fluence Energy surged nearly 100% in a week on big contract wins and a growing backlog. A quartet of AI-exposed energ...
Wells Fargo lowers Meta's price target to 765 but preserves a bullish view as Meta reports strong Q1 FY2026 results a...
In 2025, mackenzie scott gave away more than $7 billion to hundreds of groups through Yield Giving, but her low-profi...
Hedge funds are loading up on big software names as AI fuels new growth avenues, even as margins come under pressure....
atlas vms’s erik morin outlines how second appraisals for HECMs affect borrowers and lenders as an AIM-Port deal gain...